Functional degradation of myelin basic protein. The proteomic approach

被引:0
作者
A. V. Bacheva
A. A. Belogurov
E. S. Kuzina
M. V. Serebryakova
N. A. Ponomarenko
V. D. Knorre
V. M. Govorun
A. G. Gabibov
机构
[1] Moscow State University,Chemistry Department
[2] Russian Academy of Sciences,Institute of Bioorganic Chemistry
[3] Russian Academy of Medical Sciences,Proteomic Center, Institute of Physicochemical Medicine
来源
Russian Journal of Bioorganic Chemistry | 2011年 / 37卷
关键词
experimental autoimmune encephalomyelitis; mass spectrometry; myelin basic protein; proteases associated with multiple sclerosis; proteasome;
D O I
暂无
中图分类号
学科分类号
摘要
Proteolytic degradation of autoantigens is of prime importance in current biochemistry and immunology. The fundamental issue is the functional role of peptides produced in the process of change of the hydrolysis specificity during the transition from the normal to a pathologic state. In some cases identification of specific peptide fragments can be a diagnostic and prognostic criterion of the pathology progress. The subject of this work is the comparative study of degradation peculiarities of one of the major neuroantigens, myelin basic protein, by proteases activated upon the development of a pathological demyelinating process, and by proteasomes of different origin. Comparison of the specificity of the tested biocatalysts in some cases demonstrated critical changes in the set of myelin basic protein fragments capable of being presented on the major histocompatibility complex class I upon neurodegeneration, which may promote the development of autoimmune pathological processes.
引用
收藏
页码:39 / 47
页数:8
相关论文
共 122 条
  • [1] Rinne U.K.(1968)undefined Acta Neurol. Scand. 44 156-167
  • [2] Riekkinen P.(1990)undefined Cell Immunol. 129 22-31
  • [3] Cross A.H.(1994)undefined Immunol. Today 15 103-107
  • [4] Dolich S.(2000)undefined Vopr. Med. Khim. 6 10-27
  • [5] Raine C.S.(1994)undefined J. Clin. Invest. 94 146-154
  • [6] Opdenakker G.(1996)undefined Ann. Neurol. 40 18-24
  • [7] van Damme J.(2002)undefined FASEB J. 16 379-389
  • [8] Chekhonin V.P.(2007)undefined Appl. Microbiol. Biotechnol. 75 1353-1360
  • [9] Gurina O.I.(1994)undefined J. Biol. Chem. 269 20952-20957
  • [10] Dmitrieva T.B.(2002)undefined J. Biol. Chem. 277 13589-13596